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a major fungal pattern recognition receptor, as well as 
the Dectin-1-dependent cytokine production. Both RAR-
dependent and RAR-independent mechanisms seem to play 
a role in the atRA-mediated immunomodulation. Our find-
ings open a new direction to elucidate the role of vitamin A 
on the immune function during fungal infections.
Keywords  Vitamin A · Retinoic acid · Candida albicans · 
Dectin-1
Introduction
Vitamin A is an essential nutrient obtained through the 
diet either as provitamin-A (carotenoids) or as preformed 
vitamin A (retinol and retinyl esters) [1, 2]. In its esteri-
fied form, it can be stored in the liver, where it is continu-
ally hydrolyzed to retinol and deployed into circulation [3, 
4]. Once in its target tissues, two dehydrogenases are able 
to convert the retinol into retinoic acid, the biologically 
active metabolite of vitamin A [5]. In this form, vitamin 
A is known to play an essential role in multiple biological 
processes, including reproduction, embryogenesis, mainte-
nance of body tissues and augmentation of the immune sys-
tem [6–8]. Over the last decades, an increasing effort has 
been devoted to better define its involvement in the regu-
lation of the immune response, since vitamin A deficiency 
(VAD) has been associated with an increased susceptibility 
to severe infectious diseases [9].
Several in vitro studies have shed light into the role 
of vitamin A not only as an important factor for normal 
immune system development, but also as a modulator of 
both the innate and the adaptive immune responses [4, 
10]. Vitamin A has shown to regulate the development 
of B-lymphocytes and its immunoglobulin production 
Abstract  Beyond its well-documented role in repro-
duction, embryogenesis and maintenance of body tis-
sues, vitamin A has attracted considerable attention due to 
its immunomodulatory effects on both the innate and the 
adaptive immune responses. In infectious diseases, vitamin 
A has been shown to have a host-protective effect in infec-
tions of bacterial, viral or protozoan origin. Nevertheless, 
its impact in fungal infections remains unknown. Mean-
while, the frequency of invasive mycoses keeps on grow-
ing, with Candida albicans being the major opportunistic 
fungal pathogen and associated with high mortality. In the 
present work, we explored the impact of all-trans retinoic 
acid (atRA), the most active metabolite of vitamin A, on 
the innate immune response against C. albicans in human 
monocytes. Our results show a strong immunomodula-
tory role for atRA, leading to a significant down-regulation 
of the fungi-induced expression and secretion of the pro-
inflammatory cytokines TNFα, IL6 and IL12. Moreover, 
atRA significantly suppressed the expression of Dectin-1, 
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[11–13]. In T-cells, retinoic acid is able to attenuate the 
Th1-associated gene expression and skew the immune 
response toward a Th2 profile [14]. Retinoic acid is 
also able to modulate the LPS-induced cytokine and/
or chemokine production in further innate immune cells, 
including monocytes [15], macrophages and dendritic 
cells [16]. Moreover, the role of vitamin A as immu-
nomodulator has been reinforced by interventional studies 
with infants and children with VAD. Here, vitamin A sup-
plementation could reduce the morbidity and/or mortality 
from measles, malaria and certain forms of diarrhea [17]. 
These findings are also supported by several in vitro and 
animal studies, where a host-protective effect of vitamin 
A could be described for infections involving a bacterial, 
viral or protozoan origin [18]. Nevertheless, the ability of 
vitamin A to modulate the immune response against fungal 
infections is still unknown.
The frequency of invasive mycoses due to opportun-
istic fungal pathogens has been significantly growing in 
intensive care units over the last decades [19, 20]. Among 
invasive fungal infections in humans, Candida albicans 
remains the most important cause and is associated with 
high morbidity and mortality [21]. As shown for Candida-
induced sepsis in mice models, the fatal host damage 
results from an exaggerated immune response rather than 
from the pathogen itself [22]. Therefore, modulation of the 
immune response might be an interesting strategy to reduce 
C. albicans-associated immunopathology.
The orchestration of the antifungal response starts with 
the recognition of the pathogen by immune cells provided 
with fungal pattern recognition receptors (PRR) [23]. 
Monocytes express most of the fungal PRRs and have 
shown to play a particularly important role in the early 
recognition of the pathogen in invasive candidiasis [23, 
24]. Moreover, monocytes are the most effective mononu-
clear cell-type at killing C. albicans, while their cytokine 
secretion is important for subsequent innate and adap-
tive immune activation [23,  25]. However, inflammatory 
monocytes have also been linked to dysregulated immune 
responses in invasive candidiasis [22]. Thus, modulation 
of the immune response in monocytes might be of par-
ticular importance for the course of infection. Among the 
PRRs expressed on these innate cells, Dectin-1 has shown 
to play a prominent role in the immune response against 
C. albicans, not only mediating phagocytosis but also trig-
gering the oxidative burst and the production of several 
pro-inflammatory cytokines [26]. Hence, in the present 
study, we analyzed the immunomodulatory role of vita-
min A on the innate immune response against C. albicans 
with a main focus on the Dectin-1-mediated response. For 
this purpose, we employed β-1,3-glucan beads which were 
designed to serve as “fungal-like particles” eliciting a dom-
inant Dectin-1 response [27, 28].
Materials and methods
Material
Beta-1,3-glucan beads were prepared as previously 
described [27]. atRA was purchased from Sigma-Aldrich 
(Germany) and dissolved in absolute ethanol. The RARα-
agonist BMS753, the RARγ-agonist BMS961, as well as 
the RARα antagonist BMS195614 and the RARγ antago-
nist MM11253 were purchased from Tocris Bioscience 
(UK). Monoclonal mouse anti-human Dectin-1 MAB1859 
(clone #259931) antibody was purchased from R&D Sys-
tems (Germany). Mouse IgG2B isotype control antibody 
was purchased from eBioscience (UK). APC-conjugated 
polyclonal goat anti-mouse antibody and APC-conjugated 
monoclonal mouse anti-human CD14 antibody were pur-
chased from BD Biosciences (Germany). Polyclonal rab-
bit anti-Galectin-3 SC-20157 antibody was purchased from 
Santa Cruz (USA) and polyclonal rabbit anti-Actin (20–33) 
antibody was purchased from Sigma-Aldrich (Germany). 
HRP conjugated goat anti-rabbit IgG (H+L) antibody was 
purchased from Dianova (Germany).
Candida albicans isolate
Overnight fungal cultures of the virulent wild-type strain 
SC5314 [29] were grown in YPD medium, washed three 
times and resuspended in PBS at a concentration of 108 
yeasts/ml. To avoid overbalanced growth of C. albicans 
and monocyte-killing due to hyphae formation, we inac-
tivated the fungal yeasts. UV inactivation of the cells was 
performed on a UVC-500-Crosslinker (Amersham, UK) 
using two doses of 100,000 μj/cm2 immediately before cell 
stimulation.
Monocyte isolation
Human monocytes were isolated from buffy coats kindly 
provided by Dagmar Barz (Institute of Transfusional Medi-
cine of the Jena University Hospital). Peripheral blood 
mononuclear cells (PBMCs) were isolated by density gra-
dient centrifugation following manufacturer’s instructions. 
Briefly, blood diluted 1:1 with PBS was layered onto an 
equal volume of Ficoll-Paque Plus (GE-Healthcare, Ger-
many) and centrifuged in Leukosep Falcon tubes at 800 × g 
for 15 min. After centrifugation, the leukocyte band was 
collected, washed with cold NaCl 0.45 % and subjected 
to erythrocyte lysis using a hypotonic buffer. Cells were 
then washed twice in cold PBS and counted on a hemo-
cytometer. Cell viability was assessed by trypan blue and 
propidium iodide/AnnexinV staining. To further isolate the 
monocytes, we used the monocyte isolation kit II (Miltenyi, 
UK) which couples negative selection with a cocktail of 417 Med Microbiol Immunol (2014) 203:415–424 
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biotin-conjugated monoclonal antibodies and magnetic cell 
sorting using the quadro-MACS (Miltenyi, UK). Purity of 
the obtained monocytes was >92 % as assessed by CD14-
labeling and flow cytometric analysis.
Stimulation assays
After monocyte isolation, cells were resuspended at 
4 × 106 cells/ml in RPMI GlutaMax-Medium (Invitrogen, 
UK) supplemented with 1 % Penicillin/Streptomycin (Inv-
itrogen, UK), plated on 6-well plates (VWR International, 
Germany) and allowed to equilibrate at 37 °C for 2 h. 
Monocytes were then pre-incubated with 1 μM of atRA or 
the specific RAR agonists for 30 min, followed by addition 
of the previously prepared C. albicans yeast at a fungus-
monocyte ratio of 1:1. This ratio was predetermined in pilot 
experiments to preserve cell viability while yielding a suit-
able host gene response. When RAR antagonists were used, 
these were added 30 min before atRA, at a concentration 
of 1 μM. In the stimulation assay using β-1,3-glucan beads 
as specific ligands of Dectin-1, a 5:1 ratio was used. The 
cells were then incubated for 5 or 16 h at 37 °C and 5 % 
CO2. Viability of the monocytes was >90 %, as assessed 
by trypan blue and propidium iodide-staining. Addition-
ally, AnnexinV staining was used to exclude an increase in 
apoptotic events. After incubation, the monocytes were har-
vested for RNA isolation and the culture supernatants were 
collected and stored at −80 °C.
RT-PCR and quantitative PCR
To analyze the gene expression of the target genes, total 
RNA was isolated from 8 × 106 monocytes using the Qia-
gen RNeasy mini kit. An additional step was included to 
remove the residual genomic DNA using DNaseI (Qia-
gen, Germany). A NanoDrop D-1000 Spectrophotometer 
(Thermo-Fisher Scientific, Germany) was then used to 
assess the amount and quality of the RNA. Complemen-
tary DNA (cDNA) was synthesized from 1,5 μg of RNA 
using the High Capacity cDNA Reverse Transcription 
Kit (Applied Biosystems, UK) following manufacturer’s 
instructions. For PCR-analysis, specific primers for each 
target gene were designed using the online primer-BLAST 
tool of the National Center for Biotechnology Information 
(NCBI,  http://www.ncbi.nlm.nih.gov/tools/primer-blast/). 
In order to improve the PCR efficiency, possible second-
ary structures of the amplicons were taken into account by 
characterizing their nucleotide sequence using the Mfold 
algorithm [30]. The sequences of all primers used for 
amplification are listed in Table 1.
PCR of the cDNA was carried out on a S1000™ Thermal 
Cycler (BioRad, UK) in a 25 μl reaction volume contain-
ing 0.2 μM primers, 1 U Taq DNA polymerase (5-Prime, 
UK) and 200 μM dNTPs. Thermal conditions included an 
initial 95 °C denaturation step for 3 min, and then 35 cycles 
of 10 s at 94 °C, 30 s at 60 °C and 30 s at 72 °C. The result-
ing PCR products were separated on an ethidium bromide 
stained agarose gel and visualized under a UV-transilumina-
tor to confirm the expected amplicon size.
To quantify the relative expression of each gene, a Cor-
bett Rotor-Gene 6000 (Qiagen, Germany) was used as Real-
Time qPCR apparatus. Each sample was analyzed in dupli-
cate in a total reaction volume of 20 μl containing 10 μl of 
2 × SensiMix SYBR Master Mix (Bioline, UK) and 0.2 μM 
of each primer. All qPCRs were set up using a CAS-1200 
pipetting robot (Qiagen, Germany). The cycling conditions 
were 95 °C for 10 min followed by 40 cycles of 95 °C for 
15 s, 60 °C for 20 s and 72 °C for 20 s. For each experiment, 
an RT-negative sample was included as control. Specificity 
of the qPCRs was assessed by melting curve analysis and 
size verification by electrophoresis. The relative expression 
of the target genes was analyzed using a modified Pfaffl  
Table 1   Sequence of forward and reverse primers of indicated target genes and the size expected for each PCR product
Human gene Symbol Forward primer Reverse primer Size (bp)
Peptidylpropyl isomerase B PPIB ATGTAGGCCGGGTGATCTTT TGAAGTTCTCATCGGGGAAG 219
Hypoxanthine phosphoribosyltransferase 1 HPRT1 GACCAGTCAACAGGGGACAT AACACTTCGTGGGGTCCTTTTC 195
Tumor necrosis factor alpha TNFα TTCTCCTTCCTGATCGTGGC ACTCGGGGTTCGAGAAGATG 150
Interleukin 6 IL6 GAGGAGACTTGCCTGGTGAA TGGGTCAGGGGTGGTTATTG 186
Interleukin 10 IL10 GCTGAGAACCAAGACCCAGA GCATTCTTCACCTGCTCCAC 143
Interleukin 12 subunit beta IL12B ACAACATCTGTTTCAGGGCCA GGTCCAAGGTCCAGGTGATA 239
Dectin-1 CLEC7A ACACTTCGACTCTCAAAGCA TACAGCAATGAGGCGCCAA 91
Toll-like receptor 2 TLR2 TGCATTCCCAAGACACTGGA AGGGAGGCATCTGGTAGAGT 131
Galectin-3 LGALS3 CCCATCTTCTGGACAGCCAA CTTCACCGTGCCCAGAATTG 151
Retinoic acid receptor alpha RARA CCACATGTTCCCCAAGATGC GCCCTCTGAGTTCTCCAACA 145
Retinoic acid receptor beta RARB TCGTCTGCCAGGACAAATCA TTGGCATCGATTCCTGGTGA 158
Retinoic acid receptor gamma RARG CAAGGTCAGCAAAGCCCATC ACTTGGTAGCCAGCTCACTG 137418   Med Microbiol Immunol (2014) 203:415–424
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method [31, 32]. To determine significant differences in the 
mRNA expression between different experimental condi-
tions, the relative quantity (RQ) for each sample was cal-
culated using the formula 1/ECt, where E is the efficiency 
and Ct the threshold cycle. The RQ was then normalized to 
the geometric mean of two housekeeping genes: hypoxan-
thine phosphoribosyltransferase1 (HPRT1) and peptidylpro-
pyl isomerase B (PPIB). The stability of the housekeeping 
genes was assessed using the BestKeeper algorithm [33]. 
The normalized RQ (NRQ) values were log2-transformed 
for further statistical analysis with GraphPad PRISM v5.0.
Flow cytometry
To analyze the expression of Dectin-1 on the cell surface, 
monocytes were washed with PBS containing 10 % FBS and 
stained with anti-Dectin-1 antibody (1 µg/ml, 30 min) and with 
APC-conjugated goat anti-mouse IgG (2,5 µg/ml, 30 min). A 
mouse-IgG2B-antibody was used as isotype control. Samples 
were measured on a FACSAria II apparatus (BD Biosciences; 
Germany) and data were analyzed using the FLOWJO 7.6.4 
software. The resulting mean fluorescence intensities (MFIs) 
were normalized to those of unstained cells in each case.
Cytokine measurements
TNFα, IL6, IL12 and IL10 secretion by the monocytes was 
analyzed using commercially available ELISA kits (Human 
TNFα Elisa Kit, Thermo Scientific; Human IL12 Elisa Kit, 
Hölzel Diagnostika; Human IL6 Elisa Kit, eBioscience; 
Human IL10 Elisa Kit, eBioscience) according to the man-
ufacturer’s instructions. An Infinite M200 reader (Tecan, 
UK) was used to measure the optical density (OD), and 
the concentration of each cytokine was calculated from the 
respective standard curve by five-parameter logistic analy-
sis using the Magellan v.6 software (Tecan, UK).
Statistical analysis
Statistical analyses were performed using GraphPad 
PRISM v5.0 software (San Diego, USA). Two-sided pair-
wise t test or repeated measures ANOVA with Dunnett’s 
post hoc test were used to determine statistical significance. 
In all cases, the level of significance was set at p ≤ 0.05.
Results
Retinoic acid modulates the cytokine production induced 
by C. albicans and β-1,3-glucan in human monocytes
We assessed the impact of vitamin A on the immune 
response to C. albicans by challenging monocytes with 
UV-killed yeasts in the absence or presence of 1 μM atRA. 
In a first approach, we analyzed the expression of TNFα, 
IL6, IL12b and IL10 at transcriptional level by Real-Time 
qPCR. For accurate normalization purposes, we tested the 
stability of the housekeeping genes among the experimen-
tal conditions using the BestKeeper algorithm [33]. Since 
both PPIB (standard deviation (SD) of the Ct = 0,48;   
coefficient of variance (CV) of the Ct = 2,60) and HPRT1 
(SD(Ct) = 0,49; CV(Ct) = 2,22) showed a highly stable 
expression, the geometric mean of both genes was used for 
further relative expression calculations.
After 5 h of incubation with C. albicans yeasts, we 
could observe a clear increase in the mRNA expression lev-
els of all four cytokines analyzed (Fig. 1a). However, in the 
presence of atRA in the cell culture medium, the up-regu-
lation of the pro-inflammatory cytokines was significantly 
suppressed. As shown in Fig. 1a, the C. albicans-mediated 
expression of TNFα could be dropped from a 78-fold 
expression (in the absence of atRA) to a 21-fold expres-
sion when atRA was present. In a similar way, we could 
observe a significant reduction of 83 and 96 % in the gene 
expression levels of IL6 and IL12b, respectively (Fig. 1a). 
This modulation by retinoic acid occurs in a dose-depend-
ent manner, and an inhibitory effect of atRA on all three 
cytokines could already be observed with concentrations 
as low as 0,01 μM (Suppl. Fig. 1). On the other hand, we 
could not observe any effect of atRA on the C. albicans-
induced IL10 expression (Fig. 1a), even if in the absence 
of fungal challenge, the addition of atRA led to an up-regu-
lation of this anti-inflammatory cytokine (data not shown).
Comparable results were obtained when the mono-
cytes were stimulated with β-1,3-glucan beads to specifi-
cally address the Dectin-1-response (Fig. 1b). As shown 
in Fig. 1b, the activation of this early fungal-recognition 
receptor, leading to an up-regulation of all three pro-
inflammatory cytokines, was down-regulated by atRA 
at transcriptional level. In contrast, the expression of the 
anti-inflammatory cytokine IL10 was rather potentiated by 
atRA, although not in a statistically significant manner.
To further confirm our findings at protein level, we ana-
lyzed the culture supernatants for the presence of TNFα, 
IL6, IL12 and IL10 after 16 h of stimulation with either 
C. albicans or β-glucan beads. As shown in Fig. 2, pro-
inflammatory cytokine secretion upon fungal stimulation 
was severely affected by atRA. Co-stimulation with atRA 
decreased the amount of secreted TNFα, IL6 and IL12 in a 
significant manner, whereas no effect could be observed on 
the IL10 release. (Fig. 2a). Similar results were observed 
when the monocytes were stimulated with the β-glucan 
beads. In this case, atRA showed an inhibitory effect on 
the release of all pro-inflammatory cytokines, whereas the 
secretion of IL10 was rather potentiated (Fig. 2b). These 
observations resemble the results obtained at transcriptional 419 Med Microbiol Immunol (2014) 203:415–424 
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level and suggest a strong anti-inflammatory role of vita-
min A in fungal infections.
Retinoic acid modulates the expression of Dectin-1
Since we could observe an impact of vitamin A on the func-
tion of Dectin-1 in terms of the receptor-mediated cytokine 
production, we next wanted to investigate whether vitamin 
A had an effect on the expression of this PRR. Under the 
experimental settings of our stimulation assay, the expres-
sion of Dectin-1 was measured at transcriptional level after 
5 and 16 h of incubation with C. albicans. At both time 
points, atRA supplementation led to a decreased expres-
sion of Dectin-1 mRNA. Moreover, the inhibitory effect 
of atRA seemed to increase over time, reaching a fivefold 
down-regulation of Dectin-1 mRNA after 16 h of incuba-
tion with C. albicans (Fig. 3a). Similar down-regulation was 
also observed when cells were stimulated with atRA alone, 
in the absence of fungal challenge (Suppl. Fig. 2). Interest-
ingly, C. albicans itself was also able to slightly dampen the 
expression of Dectin-1 at transcriptional level (Fig. 3a).
Next, we explored the expression of Dectin-1 on the cell 
surface of the monocytes. As shown in Fig. 3b, our findings 
at transcriptional level could be reproduced at protein level 
by flow cytometry. A shift in the MFI became apparent after 
C. albicans stimulation and reached its maximum drop in 
the presence of atRA (Fig. 3b). To further assess the impact 
of atRA on Dectin-1 over time, relative MFI values were 
calculated for each time point. In agreement with the obser-
vations at transcriptional level, the atRA-mediated down-
regulation of Dectin-1 increased over time as assessed by 
a trend test (Page’s L test; p < 0.001; Fig. 3c). These results 
suggest a sustained modulation of the anti-fungal response 
by vitamin A. Moreover, when we analyzed the influence 
of atRA on the expression pattern of two known co-recep-
tors of Dectin-1, TLR2 and Galectin-3, a highly significant 
down-regulation could be observed in both cases (Fig. 3d). 
While C. albicans increased the mRNA expression of both 
TLR2 and Galectin-3, this up-regulation was almost com-
pletely abrogated in the presence of atRA.
RAR-dependent and RAR-independent mechanisms 
mediate the atRA-induced anti-inflammatory effect 
in monocytes
To determine the involvement of specific nuclear receptors in 
our findings, we first characterized the expression profiles of 
all possible RARs in our monocytes by RT-PCR. We could 
not detect any expression of RARβ, but obtained a clear sig-
nal for the expression of both RARα and RARγ mRNA in all 
five monocyte samples used in this study (Fig. 4a). To define 
the relevance of these two receptors in the atRA-mediated 
anti-inflammatory effect, specific agonists and antagonists of 
each RAR were used in our experimental setting.
When the monocytes were pre-incubated with the spe-
cific RAR agonists, both RARα agonist BMS753 and 
Fig. 1   Relative mRNA expression levels of TNFα, IL6 and IL12b 
measured by qPCR. Monocytes were stimulated with either a UV-
treated C. albicans yeasts (UV-Ca) or b β-1,3-glucan beads (βG-b) 
for 5 h in the presence or absence of 1 μM atRA. Both the β-1,3-
glucan-induced and the C. albicans-mediated up-regulation of pro-
inflammatory cytokine expression was significantly attenuated by 
atRA. Data were obtained from five independent experiments, each 
performed with cells from different donors. Results are presented as 
mean ± SEM of the fold change relative to the control (unstimulated 
cells). *** p ≤ 0.001420   Med Microbiol Immunol (2014) 203:415–424
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RARγ agonist BMS961 were able to mimic the repres-
sive effect of atRA, although only partially in most cases 
(Fig. 4b). These results suggest that both RAR receptors 
are capable to mediate the observed down-regulation of 
the inflammatory response against C. albicans. To fur-
ther prove their involvement in our particular experimen-
tal setting, specific antagonists of both RARs were used 
to test whether the expression levels of each gene could 
be restored in their presence. For both TNFα and IL6, the   
C. albicans-induced expression levels could be fully 
restored in the presence of the RAR antagonists in a signifi-
cant manner (Fig. 4b). Also the expression of IL12b could 
be restored significantly, but only partially. In contrast, 
the atRA-mediated down-regulation of Dectin-1 mRNA 
was not affected by the addition of the RAR antagonists 
(Fig.  4b). Taken together, these results suggest a RAR-
dependent mechanism for the atRA-mediated modulation 
of the pro-inflammatory cytokines, whereas an additional 
RAR-independent mechanism seems to play a major role in 
the transcriptional regulation of Dectin-1.
Discussion
Despite the increasing interest in the immunomodulatory 
role of vitamin A, no evidence has been reported address-
ing the impact of vitamin A on the immune response to 
fungi. In the present study, we have characterized the effect 
of atRA on the C. albicans-induced immune response in 
human monocytes. Our results show a strong immunomod-
ulatory role for atRA, leading to a highly significant sup-
pression of the fungi-induced expression of TNFα, IL6 and 
IL12. This down-regulation could be assessed at both tran-
scriptional and post-translational level.
In fungal infections, the immune response is initiated 
after recognition of the pathogen by specific PRRs, such as 
Dectin-1 [26]. To address the impact of vitamin A on this 
important receptor in the fungal immune activation, we 
stimulated the monocytes using β-1,3-glucan beads as spe-
cific Dectin-1 ligand. Under these conditions, the modula-
tory effect of atRA resembled the one observed in experi-
ments performed with C. albicans. Besides the impact of 
atRA on the functional output of Dectin-1 activation, we 
investigated the effect of atRA on the expression of the 
receptor upon C. albicans challenge. Interestingly, C. albi-
cans alone was able to down-regulate the expression of 
Dectin-1, which has not been described previously in the 
literature. This observation might suggest a new mecha-
nism to be included in the growing record of immune-
escaping strategies described for this fungus [34,  35]. 
When atRA was added in this experimental setting, an even 
stronger inhibitory impact on the expression of Dectin-1 
could be observed. The atRA-mediated down-regulation 
of the receptor could be assessed at transcriptional level 
and by flow cytometry. The inhibitory effect of atRA was 
not challenge-dependent, since a similar effect could be 
observed in the absence of C. albicans (Suppl. Fig. 2). This 
effect seems also not to be related to a process of atRA-
induced differentiation, since a comparable down-regula-
tion of Dectin-1 could be observed when terminally dif-
ferentiated dendritic cells were stimulated with atRA (data 
not shown). Moreover, we could demonstrate that the sup-
pressive effect of atRA increased over time, which suggests 
that the immunomodulatory impact of vitamin A might be 
sustained over a prolonged period. In addition, the known 
Dectin-1 co-receptors TLR2 [36] and Galectin-3 [37], 
which have been shown to enhance the Dectin-1-dependent 
immune response, were also down-regulated by atRA.
Fig. 2   Cytokine measurement in the culture supernatants. Monocytes 
were stimulated with either a UV-treated C. albicans yeasts (UV-Ca) 
or b β-1,3-glucan beads (βG-b) in the presence or absence of 1 μM 
atRA. After 16 h culture supernatants were analyzed using specific 
ELISAs for TNFα, IL6, IL12 and IL10. In the presence of atRA, the 
secretion of all pro-inflammatory cytokines was significantly inhib-
ited. Columns and error bars represent the mean ± SEM of five inde-
pendent experiments. * p ≤ 0.05; ** p ≤ 0.01421 Med Microbiol Immunol (2014) 203:415–424 
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Our results raised the question whether the observed 
drop in pro-inflammatory cytokine production could 
be explained by the atRA-mediated down-regulation of 
Dectin-1 and its co-receptors. The effect of atRA on the 
cytokine expression could be observed at transcriptional 
level after 5 h of incubation. Interestingly, at this stage, the 
atRA-mediated Dectin-1 down-regulation at the cell sur-
face was already apparent, although only in a very incipi-
ent manner (Suppl. Fig. 3). Therefore, we cannot exclude 
that the down-regulation of the receptor might contribute, 
at least in part, to the observed drop in cytokine levels. 
Nevertheless, it is likely that other direct mechanisms play 
a prominent role in the early phase of the atRA-mediated 
immunomodulation. This is supported by our observa-
tion that short pre-incubation periods with atRA led to a 
stronger down-regulation of the fungi-induced cytokine 
expression than pre-incubation periods of 24 h, when the 
Dectin-1-down-regulation on the cell surface reached a 
maximum (Suppl. Fig. 4). This is also in agreement with 
the observation that atRA has been described to modu-
late the immune response to LPS, a Dectin-1-independent 
immunological challenge, at least in other cell types such 
as dendritic cells and macrophages [16].
In monocytes, the immunomodulatory role of atRA on 
the immune response against LPS has been reported by 
Oeth et al. [38] and Wang et al. [39]. While Oeth et al. 
could not detect any atRA-mediated changes in the TNFα 
secretion after stimulation with LPS, Wang et al. observed 
only a very slight impact of atRA (<twofold change) on 
the LPS-induced TNFα and IL12 mRNA expression levels. 
In our study, the addition of atRA led to an almost 100 % 
abrogation of the Dectin-1-mediated expression and secre-
tion of TNFα, IL6 and IL12 in human monocytes. It would 
be interesting to investigate whether the higher impact of 
atRA observed in our study could be related to the nature 
of the immunological challenge. The signal transduction 
of the LPS/TLR4 axis differs consistently from that of the 
Dectin-1-activation [26]. It is tempting to speculate that dif-
ferent PRR-signaling pathways might display different sen-
sitivities to atRA-modulation. Further studies are required 
to comprehensively elucidate the mechanisms of atRA-
mediated modulation of the immune response.
Fig. 3   Modulation of the Dectin-1-expression by retinoic acid upon 
C. albicans infection. Monocytes were stimulated with UV-treated C. 
albicans (CaUV) yeasts in the presence or absence of 1 μM atRA. a 
Dectin-1-mRNA expression was measured after 5 and 16 h. b Repre-
sentative flow cytometry plot of Dectin-1-APC after 24 h of stimula-
tion. c Relative Dectin-1 MFI over time. The relative MFI is defined 
as the MFI of the cells challenged with C. albicans in the presence 
of atRA divided by the MFI of the monocytes challenged with the 
fungi in the absence of atRA. d mRNA expression of Dectin-1 co-
receptors TLR2 and Galectin-3 after 5 and 16 h of stimulation. Data 
for the transcriptional analysis were obtained from five independent 
experiments, each performed with cells from different donors. Results 
are presented as mean ± SEM of the fold change relative to the con-
trol (unstimulated cells). For flow cytometry analysis, data from four 
independent experiments were collected. * p ≤ 0.05; ** p ≤ 0.01; 
*** p ≤ 0.001422   Med Microbiol Immunol (2014) 203:415–424
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Most of the biological actions of atRA are exerted 
through binding its specific nuclear receptors: RARα, 
RARβ and/or RARγ [40]. We investigated the expres-
sion of all three RARs in monocytes and could detect the 
expression of both RARα and RARγ mRNA, which is in 
agreement with previous studies [41]. The use of specific 
agonists and antagonists for each RAR allowed us to verify 
that both receptors are involved in the suppressive effects 
observed on TNFα, IL6 and IL12. On the other hand, the 
vitamin A modulation of the Dectin-1 expression seemed to 
occur mainly through a RAR-independent mechanism.
The impact of vitamins on immunity and inflamma-
tion has been widely investigated in allergy and bacterial 
infections [42], but to a much lesser extent in fungal infec-
tions. Nevertheless, vitamin D has already been described 
to possess significant anti-inflammatory properties in Can-
dida infections [43]. Meanwhile, the role of vitamin A in 
invasive candidiasis has remained unknown. Moreover, 
only very few studies have been conducted to investigate 
the vitamin A-status in septic patients, were C. albicans is 
a common nosocomial pathogen [44, 45]. Indeed, 33–55 % 
of all episodes of candidemia have been shown to occur in 
intensive care units (ICU) [46]. Such ICU-acquired candi-
demia in critically ill patients is associated with a particular 
high mortality of >50 % [47]. The search for anti-inflam-
matory immunomodulators is of particular importance 
in invasive candidiasis, where the dysregulation of the 
immune response rather than the pathogen has been shown 
to be responsible for the fatal host damage [22, 43]. Inter-
estingly, a recent study reported an important inadequacy 
of retinol and β-carotene in a cohort of sepsis patients [45]. 
Thus, monitoring the serum levels of vitamin A and its 
adequate supplementation in individuals admitted in ICUs 
might have far-reaching prophylactic implications.
In conclusion, in this study, we have demonstrated a 
strong immunomodulatory role of vitamin A on the innate 
host response to C. albicans in human monocytes. In addi-
tion, we could show that atRA modulates both the function 
and the expression of Dectin-1. Moreover, the modulation 
of this PRR seems to increase over time, leading to a sus-
tained regulation of the immune response. The observed 
effect of atRA on the cytokine production is likely to occur 
via activation of either or both RARα and RARγ. This 
study opens a new avenue to explore the role of vitamin 
A in fungal infections and to elucidate further molecular 
mechanisms of its immunomodulatory function.
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